Eminox Special Precautions

The physician should determine that the patient has a normal, healthy scalp.
Do not use hair dryer as it may reduce Eminox effectively.
Based on safety and effectivity Eminox is only given for patient age 18-65 years.
Patient should be monitored 1 month after starting therapy and at least 6 months hereafter.
Do not swallow. Accidental ingestion may produce systemic effect related to vasodilating action of Minoxidil. Signs and symptoms would most likely be cardiovascular effects associated with fluid retention, hypotension, and tachycardia. Fluid retention can be managed with appropriate diuretics treatment. Tachycardia can be controlled by administration of beta adrenergic blocking agent. Hypotension should be treated by iv administration of normal saline.
Cessation of Eminox treatment may lead to the loss of new hair growth.
Discontinue Eminox application if there is undesirable or systemic effect.
Eminox should not be used concomitantly with other topical dermatologic preparation.
Eminox should not be used in patients with coronary heart disease, arrhythmia, heart failure or valvular heart disease. If any other cardiovascular disease is present, it becomes a matter of medical judgement whether or not a patient should be permitted to use Eminox.